Product
CV09050101 mRNA vaccine
1 clinical trial
1 indication
Indication
GlioblastomaClinical trial
A Phase 1 Dose-Finding Study to Evaluate Safety and Tolerability of CVGBM in Patients With Surgically Resected Glioblastoma (GBM) or Astrocytoma With a Molecular Signature of Unmethylated GlioblastomaStatus: Active (not recruiting), Estimated PCD: 2026-03-30